The U.K. is launching a scheme that would fast track breakthrough medicines to patients on the NHS before the therapies are approved in Europe. The catch is the scheme lacks financial support from government to pay for the drugs.

The Early Access to Medicines Scheme is one of the deliverables from the government's strategy for U.K. life sciences, which was launched in 2011.